DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
- 1 March 2007
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 355 (1), 72-77
- https://doi.org/10.1016/j.bbrc.2007.01.121
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activityOncogene, 2004
- Molecular Basis for Rho GTPase Signaling SpecificityBreast Cancer Research and Treatment, 2004
- DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomasOncogene, 2003
- Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cellsOncogene, 2003
- Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cellsOncogene, 2003
- DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicityOncogene, 2003
- Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancersCancer Genetics and Cytogenetics, 2003
- Morphological Changes and Detachment of Adherent Cells Induced by p122, a GTPase-activating Protein for RhoPublished by Elsevier BV ,1999
- Rho GTPases and the Actin CytoskeletonScience, 1998
- The Cellular Functions of Small GTP-Binding ProteinsScience, 1990